JMJ16 is a member of the KDM5/JARID1 family of histone demethylases that specifically removes methyl groups from histone H3 lysine 4 (H3K4me1/2/3) . Key features include:
| Property | Detail |
|---|---|
| Gene ID | AT5G46910 (Arabidopsis thaliana) |
| Enzyme Activity | H3K4me1/2/3 demethylase |
| Biological Role | Negative regulator of leaf senescence and plant defense pathways |
| Mutant Phenotype | Early leaf senescence, silique abortion, altered stress responses |
| Target Genes | WRKY53, SAG201, PR1 (pathogenesis-related genes) |
JMJ16 suppresses age-dependent leaf senescence by demethylating H3K4me3 at senescence-associated genes (SAGs):
Loss-of-function mutants (jmj16-1, jmj16-2, jmj16-3) exhibit premature leaf senescence and elevated H3K4me3 levels at SAG loci .
Key Targets:
WRKY53: A transcription factor promoting senescence.
SAG201: A senescence-associated gene with upregulated expression in mutants.
JMJ16 protein abundance decreases with aging, correlating with increased H3K4me3 at target loci .
JMJ16 negatively regulates defense responses against pathogens:
Mutant Phenotype: jmj16 and jmj18 mutants show reduced bacterial load (Pseudomonas syringae), indicating enhanced pathogen resistance .
Mechanism: Modulates salicylic acid biosynthesis and PR1 gene expression .
While the provided sources do not explicitly describe the JMJ16 antibody, its inferred uses in research include:
JMJ16 shares functional overlap with other H3K4 demethylases:
| Protein | Target | Role | Mutant Phenotype |
|---|---|---|---|
| JMJ15 | H3K4me3 | Salt stress response | Altered WRKY46/70 expression |
| JMJ18 | H3K4me3 | Chromatin function, development | Enhanced pathogen resistance |
Antibody Validation: No studies in the provided sources explicitly validate JMJ16 antibody specificity or epitopes.
Stress Responses: JMJ16’s role in abiotic stress (e.g., salinity, drought) remains unexplored, unlike JMJ15 .
Cross-species Conservation: Homologs in crops (e.g., rice, wheat) could reveal broader agricultural applications.
JMJ16 (also known as PKDM7D) is a member of the KDM5 group of proteins that specifically mediates demethylation of mono-, di-, and trimethylated H3K4 (H3K4me1/2/3) in plants. It plays a crucial role in negatively regulating age-dependent leaf senescence through its demethylase activity. JMJ16 represses the expression of positive senescence regulators like WRKY53 and SAG201 by reducing H3K4me3 levels at these loci. Its significance lies in revealing how dynamic histone modifications control developmental timing processes in plants, making it an important target for antibody-based detection in epigenetic studies .
JMJ16 antibodies are specifically designed to recognize the unique epitopes of the JMJ16 protein in Arabidopsis. Unlike antibodies against other JmjC-family proteins such as JMJ14, JMJ16 antibodies target a protein that specifically demethylates H3K4me1/2/3 but not other histone marks like H3K9, H3K27, or H3K36. This specificity is critical when studying the particular demethylase activities in different developmental contexts. When selecting a JMJ16 antibody, researchers should verify its species specificity (typically Arabidopsis-specific) and confirm it doesn't cross-react with other JmjC domain-containing proteins like JMJ14, which has distinct biological functions despite structural similarities .
The H3K4 demethylase activity of JMJ16 has been experimentally verified through both in vivo and in vitro assays. In transient expression experiments in Nicotiana benthamiana leaves, cells expressing JMJ16-YFP-HA showed substantially reduced H3K4me1/2/3 signals compared to non-transfected cells. Importantly, when the conserved iron-binding amino acids His-381 and Glu-383 of JMJ16 were replaced with Alanine (creating JMJ16m-YFP-HA), the H3K4 demethylase activity was abolished. In vitro demethylase assays further confirmed this activity. These experimental approaches provide essential positive controls for researchers validating newly developed JMJ16 antibodies .
JMJ16 antibodies are valuable tools for multiple experimental approaches in plant epigenetics research. The primary applications include:
Chromatin Immunoprecipitation (ChIP) assays to identify genomic regions where JMJ16 binds and potentially regulates H3K4me3 levels
Western blotting to detect JMJ16 protein levels during different developmental stages or stress conditions
Immunofluorescence microscopy to visualize subcellular localization of JMJ16
Co-immunoprecipitation to identify JMJ16 protein interaction partners
For optimal results, researchers should validate antibody specificity using jmj16 knockout mutants as negative controls. The antibody dilutions would typically follow similar parameters to other JmjC family proteins, with recommended dilutions of 1:1000 for Western blotting and 1:100-1:500 for immunohistochemistry applications .
When designing ChIP-seq experiments with JMJ16 antibodies, researchers should:
Validate antibody specificity using jmj16 loss-of-function mutants as negative controls
Consider using epitope-tagged JMJ16 (e.g., JMJ16-HA) expressed under its native promoter in a jmj16 background as a positive control
Perform preliminary ChIP-qPCR on known targets like WRKY53 and SAG201 before proceeding to sequencing
Include appropriate input controls and IgG controls
The ChIP-seq analysis should focus on identifying JMJ16 binding sites and correlating them with H3K4me3 levels. Based on previous studies, JMJ16 binding is enriched in both transcription start site (TSS) regions and gene bodies. Researchers should pay particular attention to senescence-associated genes, as 325 such genes have been identified as JMJ16 targets with H3K4me3 hypermethylation in jmj16 mutants .
Essential experimental controls when working with JMJ16 antibodies include:
| Control Type | Purpose | Implementation |
|---|---|---|
| Negative control | Validate antibody specificity | Use tissue from jmj16 knockout lines |
| Peptide competition | Confirm epitope specificity | Pre-incubate antibody with excess of immunizing peptide |
| Positive control | Validate antibody sensitivity | Use tissue with known JMJ16 overexpression |
| Cross-reactivity test | Ensure JMJ16 specificity | Test against other JmjC family proteins (e.g., JMJ14) |
| Loading control | Ensure equal loading in immunoblots | Detect a housekeeping protein like actin or GAPDH |
Additionally, for co-localization studies, researchers should include controls comparing JMJ16 localization with known nuclear markers, as JMJ16 functions in the nucleus to modify chromatin .
JMJ16 antibodies can be powerful tools for investigating age-dependent epigenetic reprogramming in plants. The protein abundance of JMJ16 gradually decreases during aging, which correlates with increased H3K4me3 levels at senescence-associated genes like WRKY53 and SAG201. Researchers can design time-course experiments using JMJ16 antibodies to:
Track changes in JMJ16 protein levels across leaf developmental stages
Correlate JMJ16 binding patterns with H3K4me3 dynamics at target loci
Investigate how environmental stressors affect JMJ16 stability and function
Examine the relationship between JMJ16 levels and senescence marker expression
These experiments would typically involve ChIP-seq or ChIP-qPCR analysis at multiple time points, coupled with RNA-seq to correlate binding with transcriptional changes. By mapping the temporal dynamics of JMJ16 binding and H3K4me3 modification, researchers can gain insights into the epigenetic mechanisms controlling the transition to senescence .
Understanding JMJ16's interactions with other proteins is crucial for experimental design. While specific JMJ16 interactors are not fully described in the search results, we can draw parallels from related proteins. For instance, TRB proteins have been shown to interact with the H3K4 demethylase JMJ14 and coordinate with PRC2 to repress target genes through H3K27me3 deposition and H3K4me3 removal.
For investigating JMJ16 protein interactions, researchers should:
Perform co-immunoprecipitation with JMJ16 antibodies followed by mass spectrometry
Consider techniques like BiFC (Bimolecular Fluorescence Complementation) to visualize interactions
Validate interactions with reciprocal pull-downs using antibodies against suspected partners
Perform ChIP-re-ChIP experiments to identify regions where JMJ16 co-localizes with other chromatin regulators
When interpreting results, researchers should consider that protein complexes may form in a context-dependent manner and may vary across developmental stages or stress conditions .
Researchers frequently encounter discrepancies between JMJ16 binding patterns (ChIP-seq) and transcriptional outcomes (RNA-seq). To address these discrepancies:
Perform time-course experiments to account for delayed effects between JMJ16 binding and transcriptional changes
Integrate H3K4me3 ChIP-seq data to determine which JMJ16 binding events result in actual histone modification changes
Consider the influence of other transcriptional regulators by incorporating additional epigenetic marks
Use techniques like CUT&RUN or CUT&Tag for higher resolution binding profiles
Data analysis should focus on identifying direct targets where JMJ16 binding, H3K4me3 reduction, and transcriptional repression are all correlated. From previous studies, 370 genes exhibited both JMJ16 binding and H3K4me3 hypermethylation in jmj16 mutants, with 138 of these being senescence-associated genes that were transcriptionally upregulated. Focusing on these high-confidence targets can help resolve apparent discrepancies .
When encountering specificity issues with JMJ16 antibodies, researchers should implement the following strategies:
Validate antibodies using multiple approaches: Western blot, immunoprecipitation, and immunofluorescence
Always include jmj16 mutant tissues as negative controls
Consider epitope-tagged JMJ16 lines for comparative analysis
Test cross-reactivity with other JmjC-domain proteins, particularly JMJ14
Optimize antibody dilutions and incubation conditions specifically for plant tissues
For Western blot applications, researchers should pay attention to the expected molecular weight of JMJ16 and be aware that post-translational modifications might affect migration patterns. If commercial antibodies lack specificity, consider generating custom antibodies against unique regions of JMJ16 that have low homology to other JmjC proteins .
For visualizing JMJ16 binding patterns genome-wide, researchers should:
Perform ChIP-seq with validated JMJ16 antibodies or with epitope-tagged JMJ16 proteins (like JMJ16-HA)
Use peak-calling algorithms optimized for transcription factors or chromatin modifiers
Generate meta-gene plots to visualize binding distributions relative to gene structures
Perform motif analysis to identify sequence preferences for JMJ16 binding
When analyzing the data, researchers should pay particular attention to both transcription start site regions and gene bodies, as JMJ16 binding has been observed in both locations. Integration with H3K4me3 ChIP-seq data is essential to correlate binding with functional outcomes. Meta-gene analysis has revealed that H3K4me3 levels increase, especially at transcription start site regions, in jmj16 mutants, indicating these regions as primary sites of JMJ16 activity .
Optimizing protein extraction for JMJ16 detection requires consideration of:
Tissue-specific expression levels of JMJ16
The nuclear localization of JMJ16
Potential protein degradation during extraction
Cross-reactivity issues in complex tissue samples
Recommended protocol adjustments include:
| Tissue Type | Buffer Modifications | Special Considerations |
|---|---|---|
| Young leaves | Standard nuclear extraction buffer | Add protease inhibitors freshly |
| Senescent leaves | Add higher concentrations of protease inhibitors | Account for increased oxidative environment |
| Reproductive tissues | Include 1% polyvinylpyrrolidone | Helps remove phenolic compounds |
| Roots | Increase detergent concentration by 0.1-0.2% | Facilitates membrane disruption |
Additionally, researchers should consider using fractionation approaches to enrich for nuclear proteins before immunoblotting, as this can significantly improve detection sensitivity for chromatin-associated proteins like JMJ16 .
When interpreting changes in JMJ16 abundance during developmental transitions, researchers should consider:
The age-dependent decrease in JMJ16 protein levels is correlated with increased H3K4me3 at senescence-associated genes
This correlation suggests a regulatory mechanism where JMJ16 functions as a gatekeeper of senescence
Changes in JMJ16 abundance should be interpreted alongside changes in target gene expression and H3K4me3 levels
Environmental factors may influence the rate of JMJ16 decrease
Quantitative analysis should include normalization to appropriate housekeeping proteins and statistical analysis across biological replicates. The gradual decrease in JMJ16 abundance appears to be a programmed aspect of development rather than a response to stress, as it correlates with the natural aging process. This decrease leads to increased H3K4me3 levels at senescence-promoting genes like WRKY53 and SAG201, which consequently become activated to drive the senescence program .
Comparative studies between JMJ16 and other JmjC proteins can yield valuable insights into the evolution and specialization of histone demethylases. For example:
Unlike JMJ14 which affects flowering time, JMJ16 primarily regulates leaf senescence, suggesting functional specialization
Both JMJ14 and JMJ16 target H3K4me3, but their genomic targets appear largely distinct
Comparing binding patterns may reveal common structural features that determine substrate specificity
Evolutionary analysis may identify conserved domains important for enzymatic activity
When designing comparative experiments, researchers should use antibodies of comparable affinity and specificity for each protein. Controls should include appropriate mutant lines for each JmjC protein being studied. Meta-analysis of binding patterns can reveal unique and overlapping targets, providing insights into the division of labor among related histone demethylases .
Several emerging technologies could enhance JMJ16 research beyond traditional antibody applications:
CRISPR-based technologies:
CUT&RUN and CUT&Tag for higher resolution binding profiles
CRISPR activation/interference to manipulate JMJ16 expression
Protein tagging approaches:
Proximity labeling (BioID or TurboID) to identify JMJ16 interaction partners
FRET-based sensors to monitor JMJ16 activity in real-time
Single-cell technologies:
Single-cell ChIP-seq to examine cell-type specific binding patterns
Single-cell RNA-seq to correlate with transcriptional outcomes
Structural biology approaches:
Cryo-EM to determine JMJ16 complex structures
Hydrogen-deuterium exchange mass spectrometry to study conformational dynamics
These technologies could provide unprecedented insights into JMJ16 function at higher spatial and temporal resolution, potentially revealing cell-type specific roles and regulatory mechanisms that are missed by traditional bulk approaches .